Equilin
Equilin (7-Dehydroestrone) is an important member of the large group of oestrogenic substances and is chemically related to menformon (oestrone) . Equilin increases the growth of cortical neurons via an NMDA receptor-dependent mechanism[1][2].
Product Specifications
CAS Number
474-86-2
Product Name Alternative
7-Dehydroestrone
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/Equilin.html
Purity
99.91
Solubility
DMSO : 100 mg/mL (ultrasonic) |Ethanol : 4 mg/mL (ultrasonic)
Smiles
C[C@]1([C@](CC2)([H])C3=CCC4=C(C=CC(O)=C4)[C@@]3([H])CC1)C2=O
Molecular Formula
C18H20O2
Molecular Weight
268.35
Precautions
H302, H315, H319, H335
References & Citations
[1]David K, et al. Some biological properties of equilin. Biochem J. 1935;29 (2) :371-377.|[2]Brinton RD, et al. Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol. 1997;147 (2) :211-220.|[3]Ito F, et al. Equilin in conjugated equine estrogen increases monocyte-endothelial adhesion via NF-κB signaling. PLoS One. 2019;14 (1) :e0211462. Published 2019 Jan 30.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7096100 Inquire
Recombinant Miopithecus talapoin C-C chemokine receptor type 5 (CCR5), partial
Sign In for Pricing
View Details 
